- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about VRTX
Recent news which mentions VRTX
Why CRISPR Therapeutics Stock Is on Fire Today
May 09, 2023
From Motley Fool
This Incredible Growth Stock Has All the Hallmarks of a Prototypical Warren Buffett Stock
May 06, 2023
From Motley Fool
From Motley Fool
2 Potentially Explosive Stocks to Buy in May
May 04, 2023
From Motley Fool
3 Top Healthcare Stocks to Buy in May
May 04, 2023
From Motley Fool
Tickers
VRTX
From Motley Fool
Vertex Pharmaceuticals, Transocean, And 'One Of The Best Companies' In Staples: CNBC's 'Final Trades'
May 03, 2023
From Benzinga
From Motley Fool
Baird Maintains Neutral Rating for Vertex Pharmaceuticals: Here's What You Need To Know
May 02, 2023
Tickers
VRTX
From Benzinga
From Motley Fool
From Motley Fool
From Motley Fool
Tickers
VRTX
From Motley Fool
Earnings Scheduled For May 1, 2023
May 01, 2023
From Benzinga
The Best Stocks to Invest $5,000 in Right Now
May 01, 2023
From Motley Fool
From Motley Fool
3 Unstoppable Stocks to Buy Right Now
April 29, 2023
From Motley Fool
ImmunoGen Boosts Annual Guidance On Upbeat Uptake Of Newly Approved Ovarian Cancer Drug
April 28, 2023
From Benzinga
2 Growth Stocks That Could Double in 5 Years
April 27, 2023
From Motley Fool
3 Cash-Rich Biotech Stocks to Bet on for the Long Haul
April 25, 2023
From InvestorPlace
From Motley Fool
3 Healthcare Stocks That Could Help Make You a Fortune
April 24, 2023
From Motley Fool
With FDA Submission For Sickle Cell Gene Therapy, Bluebird Bio Can Potentially Have 3 Approved Products By 2023
April 24, 2023
From Benzinga
The Best Stocks to Invest $20,000 in Right Now
April 23, 2023
From Motley Fool
Berkshire Hathaway, Gilead Sciences, Vertex Pharmaceuticals And A Break-Out Casino Stock Feature On CNBC's 'Final Trades'
April 21, 2023
From Benzinga
Better Big Biotech Buy: Biogen vs. Vertex
April 20, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.